Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species
- 1 March 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (3) , 881-887
- https://doi.org/10.1128/aac.01160-06
Abstract
The minimum effective concentration (MEC) used to assess the in vitro antifungal activity of caspofungin against Aspergillus spp. is a qualitative endpoint requiring microscopic examination of hyphae. We therefore developed a tool for the quantitative assessment of caspofungin activity against Aspergillus spp. at clinically applicable concentrations. Susceptibility to caspofungin (0.008 to 8 μg/ml) was studied for 9 A. fumigatus , 8 A. flavus , and 12 A. terreus isolates based on the Clinical and Laboratory Standards Institute M38-A protocol. After 48 h of incubation, the MEC was defined microscopically, and metabolic activity assessed with a modified XTT assay, using 100 μg of the tetrazolium salt XTT/ml and 6.25 μM menadione. A significant reduction in metabolic activity was demonstrated at the MEC (0.25 to 0.5 μg/ml) for all Aspergillus spp. and was more pronounced for A. flavus (median metabolic activity, 25% of control) compared to A. fumigatus and A. terreus (median metabolism, 42 and 53%, respectively), allowing determination of MEC with the XTT assay (93 to 100% agreement with microscopic MEC). Fungal metabolism tended to reach the lowest levels (median, 17 to 38% of control) one to two dilutions higher than the MEC, at the minimum metabolic activity concentration (MMC). For 5 of 9 A. fumigatus isolates, 6 of 12 A. terreus isolates, and 1 of 8 A. flavus isolates, a paradoxical increase in metabolism was observed at concentrations greater than the MMC. Sigmoid ( E max ) or bell-shaped models described accurately (median R 2 = 0.97) the concentration-dependent metabolic changes in the absence or presence, respectively, of paradoxical response. Assessment of metabolic activity may provide useful quantitative endpoints for in vitro studies of caspofungin against Aspergillus spp.Keywords
This publication has 25 references indexed in Scilit:
- Escape of Candida from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by CaspofunginAntimicrobial Agents and Chemotherapy, 2006
- Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus InfectionAntimicrobial Agents and Chemotherapy, 2006
- Assessment of the Paradoxical Effect of Caspofungin in Therapy of CandidiasisAntimicrobial Agents and Chemotherapy, 2006
- Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosisJournal of Antimicrobial Chemotherapy, 2006
- Relationship between metabolism and biomass of medically important zygomycetesMedical Mycology, 2006
- Efficacy of Caspofungin against Aspergillus terreusAntimicrobial Agents and Chemotherapy, 2005
- Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and AdolescentsAntimicrobial Agents and Chemotherapy, 2005
- Characterization ofAspergillus fumigatusmutants with reduced susceptibility to caspofunginMedical Mycology, 2005
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal TherapyClinical Infectious Diseases, 2004
- Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthaseAntimicrobial Agents and Chemotherapy, 1994